Financhill
Buy
76

AROC Quote, Financials, Valuation and Earnings

Last price:
$24.26
Seasonality move :
4.87%
Day range:
$23.54 - $24.86
52-week range:
$14.39 - $27.05
Dividend yield:
2.73%
P/E ratio:
26.98x
P/S ratio:
3.54x
P/B ratio:
3.33x
Volume:
3.6M
Avg. volume:
1.5M
1-year change:
60.35%
Market cap:
$4.3B
Revenue:
$990.3M
EPS (TTM):
$0.91

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
AROC
Archrock
$286.2M $0.29 25.88% 36.99% --
BKR
Baker Hughes
$7.2B $0.61 3.89% 46.57% $46.68
CLB
Core Laboratories
$134M $0.23 4.19% 431.25% $19.33
MPLX
MPLX LP
$3B $1.03 15.06% -5.97% $51.25
NINE
Nine Energy Service
$134.6M -$0.30 -6.51% -33.33% --
PED
PEDEVCO
$8.9M $0.02 48.9% 100% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
AROC
Archrock
$24.55 -- $4.3B 26.98x $0.18 2.73% 3.54x
BKR
Baker Hughes
$40.32 $46.68 $39.9B 18.08x $0.21 2.08% 1.48x
CLB
Core Laboratories
$16.85 $19.33 $791.1M 30.64x $0.01 0.24% 1.54x
MPLX
MPLX LP
$47.28 $51.25 $48.2B 11.15x $0.96 7.42% 4.46x
NINE
Nine Energy Service
$1.00 -- $42.4M -- $0.00 0% 0.06x
PED
PEDEVCO
$0.74 -- $66.2M 32.13x $0.00 0% 1.84x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
AROC
Archrock
63.4% 2.027 63.07% 0.78x
BKR
Baker Hughes
27.16% 1.039 16.81% 0.75x
CLB
Core Laboratories
35.81% 1.177 15.98% 1.62x
MPLX
MPLX LP
100% 0.786 49.08% 0.94x
NINE
Nine Energy Service
122.06% 3.536 665.26% 1.50x
PED
PEDEVCO
-- -1.340 -- 1.95x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
AROC
Archrock
$129.6M $95.5M 5.43% 15.16% 28.45% $26.9M
BKR
Baker Hughes
$1.5B $930M 10.26% 14.26% 15.4% $710M
CLB
Core Laboratories
$23.9M $15.6M 6.59% 10.93% 14.74% $10.4M
MPLX
MPLX LP
$1.2B $1.1B 20.2% 31.81% 46.65% $1.1B
NINE
Nine Energy Service
$15.7M $3.3M -15.34% -- 2.03% -$9.3M
PED
PEDEVCO
$3.4M $2.1M 2.3% 2.3% 23.16% $8.2M

Archrock vs. Competitors

  • Which has Higher Returns AROC or BKR?

    Baker Hughes has a net margin of 12.84% compared to Archrock's net margin of 11.09%. Archrock's return on equity of 15.16% beat Baker Hughes's return on equity of 14.26%.

    Company Gross Margin Earnings Per Share Invested Capital
    AROC
    Archrock
    44.35% $0.22 $3.5B
    BKR
    Baker Hughes
    22.32% $0.77 $22.4B
  • What do Analysts Say About AROC or BKR?

    Archrock has a consensus price target of --, signalling upside risk potential of 6.93%. On the other hand Baker Hughes has an analysts' consensus of $46.68 which suggests that it could grow by 15.77%. Given that Baker Hughes has higher upside potential than Archrock, analysts believe Baker Hughes is more attractive than Archrock.

    Company Buy Ratings Hold Ratings Sell Ratings
    AROC
    Archrock
    0 0 0
    BKR
    Baker Hughes
    14 5 0
  • Is AROC or BKR More Risky?

    Archrock has a beta of 1.598, which suggesting that the stock is 59.783% more volatile than S&P 500. In comparison Baker Hughes has a beta of 1.398, suggesting its more volatile than the S&P 500 by 39.825%.

  • Which is a Better Dividend Stock AROC or BKR?

    Archrock has a quarterly dividend of $0.18 per share corresponding to a yield of 2.73%. Baker Hughes offers a yield of 2.08% to investors and pays a quarterly dividend of $0.21 per share. Archrock pays 91.24% of its earnings as a dividend. Baker Hughes pays out 40.45% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios AROC or BKR?

    Archrock quarterly revenues are $292.2M, which are smaller than Baker Hughes quarterly revenues of $6.9B. Archrock's net income of $37.5M is lower than Baker Hughes's net income of $766M. Notably, Archrock's price-to-earnings ratio is 26.98x while Baker Hughes's PE ratio is 18.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Archrock is 3.54x versus 1.48x for Baker Hughes. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AROC
    Archrock
    3.54x 26.98x $292.2M $37.5M
    BKR
    Baker Hughes
    1.48x 18.08x $6.9B $766M
  • Which has Higher Returns AROC or CLB?

    Core Laboratories has a net margin of 12.84% compared to Archrock's net margin of 8.74%. Archrock's return on equity of 15.16% beat Core Laboratories's return on equity of 10.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    AROC
    Archrock
    44.35% $0.22 $3.5B
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
  • What do Analysts Say About AROC or CLB?

    Archrock has a consensus price target of --, signalling upside risk potential of 6.93%. On the other hand Core Laboratories has an analysts' consensus of $19.33 which suggests that it could grow by 14.74%. Given that Core Laboratories has higher upside potential than Archrock, analysts believe Core Laboratories is more attractive than Archrock.

    Company Buy Ratings Hold Ratings Sell Ratings
    AROC
    Archrock
    0 0 0
    CLB
    Core Laboratories
    0 3 1
  • Is AROC or CLB More Risky?

    Archrock has a beta of 1.598, which suggesting that the stock is 59.783% more volatile than S&P 500. In comparison Core Laboratories has a beta of 2.352, suggesting its more volatile than the S&P 500 by 135.22%.

  • Which is a Better Dividend Stock AROC or CLB?

    Archrock has a quarterly dividend of $0.18 per share corresponding to a yield of 2.73%. Core Laboratories offers a yield of 0.24% to investors and pays a quarterly dividend of $0.01 per share. Archrock pays 91.24% of its earnings as a dividend. Core Laboratories pays out 5.09% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios AROC or CLB?

    Archrock quarterly revenues are $292.2M, which are larger than Core Laboratories quarterly revenues of $134.4M. Archrock's net income of $37.5M is higher than Core Laboratories's net income of $11.7M. Notably, Archrock's price-to-earnings ratio is 26.98x while Core Laboratories's PE ratio is 30.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Archrock is 3.54x versus 1.54x for Core Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AROC
    Archrock
    3.54x 26.98x $292.2M $37.5M
    CLB
    Core Laboratories
    1.54x 30.64x $134.4M $11.7M
  • Which has Higher Returns AROC or MPLX?

    MPLX LP has a net margin of 12.84% compared to Archrock's net margin of 37.36%. Archrock's return on equity of 15.16% beat MPLX LP's return on equity of 31.81%.

    Company Gross Margin Earnings Per Share Invested Capital
    AROC
    Archrock
    44.35% $0.22 $3.5B
    MPLX
    MPLX LP
    43.88% $1.01 $22.6B
  • What do Analysts Say About AROC or MPLX?

    Archrock has a consensus price target of --, signalling upside risk potential of 6.93%. On the other hand MPLX LP has an analysts' consensus of $51.25 which suggests that it could grow by 8.4%. Given that MPLX LP has higher upside potential than Archrock, analysts believe MPLX LP is more attractive than Archrock.

    Company Buy Ratings Hold Ratings Sell Ratings
    AROC
    Archrock
    0 0 0
    MPLX
    MPLX LP
    5 5 0
  • Is AROC or MPLX More Risky?

    Archrock has a beta of 1.598, which suggesting that the stock is 59.783% more volatile than S&P 500. In comparison MPLX LP has a beta of 1.426, suggesting its more volatile than the S&P 500 by 42.634%.

  • Which is a Better Dividend Stock AROC or MPLX?

    Archrock has a quarterly dividend of $0.18 per share corresponding to a yield of 2.73%. MPLX LP offers a yield of 7.42% to investors and pays a quarterly dividend of $0.96 per share. Archrock pays 91.24% of its earnings as a dividend. MPLX LP pays out 83.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios AROC or MPLX?

    Archrock quarterly revenues are $292.2M, which are smaller than MPLX LP quarterly revenues of $2.8B. Archrock's net income of $37.5M is lower than MPLX LP's net income of $1B. Notably, Archrock's price-to-earnings ratio is 26.98x while MPLX LP's PE ratio is 11.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Archrock is 3.54x versus 4.46x for MPLX LP. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AROC
    Archrock
    3.54x 26.98x $292.2M $37.5M
    MPLX
    MPLX LP
    4.46x 11.15x $2.8B $1B
  • Which has Higher Returns AROC or NINE?

    Nine Energy Service has a net margin of 12.84% compared to Archrock's net margin of -7.34%. Archrock's return on equity of 15.16% beat Nine Energy Service's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AROC
    Archrock
    44.35% $0.22 $3.5B
    NINE
    Nine Energy Service
    11.35% -$0.26 $260.9M
  • What do Analysts Say About AROC or NINE?

    Archrock has a consensus price target of --, signalling upside risk potential of 6.93%. On the other hand Nine Energy Service has an analysts' consensus of -- which suggests that it could fall by --. Given that Archrock has higher upside potential than Nine Energy Service, analysts believe Archrock is more attractive than Nine Energy Service.

    Company Buy Ratings Hold Ratings Sell Ratings
    AROC
    Archrock
    0 0 0
    NINE
    Nine Energy Service
    0 0 0
  • Is AROC or NINE More Risky?

    Archrock has a beta of 1.598, which suggesting that the stock is 59.783% more volatile than S&P 500. In comparison Nine Energy Service has a beta of 3.504, suggesting its more volatile than the S&P 500 by 250.441%.

  • Which is a Better Dividend Stock AROC or NINE?

    Archrock has a quarterly dividend of $0.18 per share corresponding to a yield of 2.73%. Nine Energy Service offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Archrock pays 91.24% of its earnings as a dividend. Nine Energy Service pays out -- of its earnings as a dividend. Archrock's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios AROC or NINE?

    Archrock quarterly revenues are $292.2M, which are larger than Nine Energy Service quarterly revenues of $138.2M. Archrock's net income of $37.5M is higher than Nine Energy Service's net income of -$10.1M. Notably, Archrock's price-to-earnings ratio is 26.98x while Nine Energy Service's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Archrock is 3.54x versus 0.06x for Nine Energy Service. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AROC
    Archrock
    3.54x 26.98x $292.2M $37.5M
    NINE
    Nine Energy Service
    0.06x -- $138.2M -$10.1M
  • Which has Higher Returns AROC or PED?

    PEDEVCO has a net margin of 12.84% compared to Archrock's net margin of 32.21%. Archrock's return on equity of 15.16% beat PEDEVCO's return on equity of 2.3%.

    Company Gross Margin Earnings Per Share Invested Capital
    AROC
    Archrock
    44.35% $0.22 $3.5B
    PED
    PEDEVCO
    38% $0.03 $106.5M
  • What do Analysts Say About AROC or PED?

    Archrock has a consensus price target of --, signalling upside risk potential of 6.93%. On the other hand PEDEVCO has an analysts' consensus of -- which suggests that it could grow by 143.24%. Given that PEDEVCO has higher upside potential than Archrock, analysts believe PEDEVCO is more attractive than Archrock.

    Company Buy Ratings Hold Ratings Sell Ratings
    AROC
    Archrock
    0 0 0
    PED
    PEDEVCO
    2 0 0
  • Is AROC or PED More Risky?

    Archrock has a beta of 1.598, which suggesting that the stock is 59.783% more volatile than S&P 500. In comparison PEDEVCO has a beta of 0.514, suggesting its less volatile than the S&P 500 by 48.63%.

  • Which is a Better Dividend Stock AROC or PED?

    Archrock has a quarterly dividend of $0.18 per share corresponding to a yield of 2.73%. PEDEVCO offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Archrock pays 91.24% of its earnings as a dividend. PEDEVCO pays out -- of its earnings as a dividend. Archrock's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios AROC or PED?

    Archrock quarterly revenues are $292.2M, which are larger than PEDEVCO quarterly revenues of $9.1M. Archrock's net income of $37.5M is higher than PEDEVCO's net income of $2.9M. Notably, Archrock's price-to-earnings ratio is 26.98x while PEDEVCO's PE ratio is 32.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Archrock is 3.54x versus 1.84x for PEDEVCO. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AROC
    Archrock
    3.54x 26.98x $292.2M $37.5M
    PED
    PEDEVCO
    1.84x 32.13x $9.1M $2.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.09% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.53% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock